North America Analysis
Home Search

gene therapy - search results

If you're not happy with the results, please do another search
diabetes

Diabetes: A paradigm case for rewarding innovation in value-based healthcare

Prof Dr Freimut Schliess, Director of Science & Innovation at Profil Institut für Stoffwechselforschung GmbH explains the important role of innovation when it comes to healthy living and active ageing, including his thoughts on the diabetes paradigm
environmental toxicology

Environmental Toxicology: How chemicals interact with environmental species and human physiology

The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) give a detailed perspective on environmental toxicology, a life science discipline that seeks to understand how chemicals, both natural and man-made, can interact with environmental species and human physiology to cause harm
human health

Nanomedicines: Depicting human health risks hindering clinical translation

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
curing cancer

The challenge of curing cancer in the world’s children

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
acute myeloid leukaemia

Improving acute myeloid leukaemia (AML) outcomes

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved
chronic inflammatory lung diseases

Asthma: Understanding chronic inflammatory lung diseases

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective
disease-associated myosteatosis fish oil

Disease-associated myosteatosis in people with cancer: Can it be treated?

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

Why the European Pillar of Social Rights should keep nurses in the profession

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations (EFN) tell us why the European Pillar of Social Rights should help nurses to remain in the nursing profession
rare disease therapies

Access to rare disease therapies in Europe

Simone Boselli, Public Affairs Director of EURORDIS shares the fascinating findings of a new position paper that offers a synthesis of their analysis, reflections and perspectives on access to rare disease therapies in Europe today
biomedical imaging

The role of advanced technologies in healthcare

The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government
Diabetes & peripheral arterial disease

Diabetes & peripheral arterial disease

A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
Cancer research and training

Cancer research and training in the United States

The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD)

Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
metabolomics studies

Acute myeloid leukaemia (AML) research and application

The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
Pathologists

Empowering pathologists with artificial intelligence (AI)

Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.
Experimental Pathology Service - Institute of Pathology

Paediatric sarcoma metastasis: an area that warrants in-depth exploration

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...
e-health

The emergence of personalised e-health care

CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
parkinson's disease

New research may benefit patients with early stage Parkinson’s disease

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
early diagnosis

Dementia research: Early diagnosis of brain disorders

Jon Snaedal, professor in Geriatric Medicine, Landspitali University Hospital in Reykjavik, Iceland shares his expertise on dementia research including the early diagnosis of brain disorders
skin diseases

Arthritis, musculoskeletal and skin diseases including muscular dystrophy

The work of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, including muscular dystrophy (MD), is placed under the spotlight by Open Access Government

Follow Open Access Government